Betel Leaf Essential Oil Reverses Antibiotic Resistance in Staphylococcus aureus in Laboratory Study

A leaf long chewed across South and Southeast Asia for its warming, peppery bite may hold an unexpected answer to one of modern medicine’s most stubborn problems. Researchers in Vietnam report that essential oil distilled from Piper betle, the betel vine, not only kills Staphylococcus aureus in the laboratory but does something far rarer: after a full month of continuous exposure, the bacterium showed no sign of developing resistance to the oil, and populations that had already evolved resistance to conventional antibiotics became markedly more vulnerable to them again. The work, published in the journal 3 Biotech, offers a detailed in vitro portrait of how a plant-derived mixture can simultaneously blunt bacterial virulence and restore the potency of existing drugs.

The team, led by Le Minh Bui of Nguyen Tat Thanh University and Anh Duy Do of HUTECH University, set out to test a question that goes to the heart of antimicrobial stewardship. When bacteria are exposed to antibiotics at doses too low to kill them, they adapt. That adaptation is not limited to surviving the drug in question; it often spills over into cross-resistance against unrelated compounds and, troublingly, into heightened virulence. Sub-inhibitory concentrations of antibiotics have been shown in earlier studies to crank up the expression of quorum-sensing regulators and toxin genes in staphylococci, meaning that the very conditions that breed resistance can also make the surviving cells more dangerous. Whether a natural product could sidestep this double hazard was the central hypothesis of the new study.

To find out, the researchers subjected a standard laboratory strain of S. aureus, ATCC 25923, to thirty days of adaptive evolution under sub-inhibitory pressure from either Piper betle essential oil or three conventional antibiotics: chloramphenicol, streptomycin, and kanamycin. This kind of prolonged exposure experiment is a demanding test. It mimics, in simplified form, the sustained low-dose drug environments that occur in treated tissues and biofilms, and it gives the bacterial populations ample opportunity to select for resistant variants. The design allowed direct comparison of how the pathogen responds evolutionarily to a multicomponent plant oil versus single-target antibiotics.

The contrast between the two trajectories was stark. Populations evolved under chloramphenicol, streptomycin, or kanamycin developed high-level resistance to their selecting drug and displayed extensive cross-resistance, consistent with the well-documented tendency of single-molecule antibiotics to drive rapid resistance evolution. At the same time, quantitative analysis of gene expression revealed that these antibiotic-adapted populations had upregulated a suite of quorum-sensing and virulence-associated genes, including agrA, a core component of the staphylococcal quorum-sensing circuit; luxS, the gene responsible for producing the signalling molecule autoinducer-2; and hla and hlb, which encode the alpha- and beta-toxins that damage host cells. In other words, a month of antibiotic pressure produced bacteria that were harder to kill and, on the genetic evidence, potentially more aggressive.

The populations evolved under Piper betle essential oil told a different story. Over the same thirty days, the minimum inhibitory concentration of the oil did not measurably increase, indicating that no detectable resistance had emerged, and the adapted populations showed no cross-resistance to the tested antibiotics. Instead, antibiotic susceptibility was maintained or even enhanced. Gene expression profiling of the oil-adapted populations showed increased transcription of rot, a repressor of toxins in S. aureus, together with reduced expression of genes tied to quorum sensing, toxin production, and biofilm formation. The overall picture is of a bacterial population that, under continuous oil pressure, becomes less rather than more virulent, a pattern that runs counter to what conventional antibiotics produced in the same experiment.

The most clinically striking result came when the researchers tested how the oil-adapted and antibiotic-adapted populations responded to antibiotics in the presence of the oil. In both wild-type and antibiotic-adapted backgrounds, supplementation with Piper betle essential oil enhanced antibiotic susceptibility, with the minimum inhibitory and minimum bactericidal concentrations of the antibiotics dropping by factors of four to thirty-two in the antibiotic-adapted populations. For bacteria that had spent a month becoming resistant to chloramphenicol, streptomycin, or kanamycin, the oil effectively pulled them back toward sensitivity. This potentiating effect, sometimes described as antibiotic re-sensitisation, is precisely the kind of activity sought in adjunctive therapies designed to extend the useful life of existing drugs rather than replace them.

Why does the oil behave this way? The authors probed one candidate mechanism by supplementing cultures with exogenous AI-2, the autoinducer molecule produced by the LuxS enzyme. Adding AI-2 partially restored antibiotic resistance in the presence of the oil, an observation that implicates modulation of the LuxS/AI-2 signalling system in the re-sensitisation effect. The LuxS/AI-2 pathway, best known as a universal quorum-sensing signal across bacterial species, has previously been linked in S. aureus to antibiotic susceptibility and autolysis, and disrupting it has been proposed as a route to weakening biofilms and restoring drug activity. The partial nature of the restoration, however, is an important caveat: AI-2 signalling appears to contribute to the oil’s effect, but the researchers are careful to note that it may not be the sole or even the predominant mechanism. Essential oils are complex multicomponent mixtures, and their biological activity typically arises from multiple compounds acting on multiple cellular targets, from membrane disruption to interference with regulatory networks.

That multicomponent character may also explain the absence of resistance development. Single-molecule antibiotics present bacteria with a well-defined target, and a single mutation that alters that target or pumps the drug out can confer substantial protection. Plant essential oils, by contrast, present a shifting constellation of weakly acting compounds, few of which exert enough selective pressure on any one target to favour a simple resistance mutation. Prior work on Piper betle supports this framing: the oil and its constituents, including the phenolic compound hydroxychavicol, have been shown to damage bacterial DNA, inhibit cell division, and disrupt membranes, while eugenol, another prominent constituent, provokes reactive oxygen species-mediated membrane damage. Recent studies have also reported synergy between Piper betle oil and antibiotics against methicillin-resistant S. aureus clinical isolates, including computational evidence pointing at the resistance determinant PBP2a.

The context for this work is sobering. Staphylococcus aureus remains one of the world’s most consequential pathogens, colonising roughly a third of the human population in the nose and causing illnesses that range from skin abscesses to fulminant bloodstream infections, bone and joint disease, and endocarditis. Global surveillance reports document rising resistance across clinical isolates, and methicillin-resistant strains continue to limit treatment options. Beyond resistance, the bacterium’s reliance on quorum-sensing circuits such as the agr system and on biofilm formation makes chronic infections, including those associated with implanted devices and chronic rhinosinusitis, particularly difficult to eradicate. Antivirulence strategies, which aim to disarm the pathogen rather than kill it outright, are attractive in principle because they may impose less selective pressure for resistance, and the new study suggests that a traditional medicinal plant can deliver both antivirulence and resistance-reversing activity in a single preparation.

The authors are appropriately measured about what the findings do and do not establish. All experiments were conducted in vitro with a single reference strain, and the study’s own data show that the AI-2 mechanism is only partially responsible for the observed effects. Before any broader therapeutic conclusions can be drawn, the oil’s activity must be validated against methicillin-resistant S. aureus and against genetically diverse clinical isolates, which often behave quite differently from laboratory strains. Dosing, toxicity, and formulation questions, particularly for potential applications such as intranasal treatment of colonisation or biofilm-associated sinus disease, remain entirely open. Nevertheless, the combination of results reported here, no resistance emergence over a month of exposure, reversal of antibiotic resistance in adapted populations, and coordinated downregulation of virulence and biofilm genes, marks Piper betle essential oil as a candidate worthy of the deeper investigation that must now follow.

Subject of Research: Evaluation of Piper betle essential oil as an antivirulence agent and antibiotic potentiator against Staphylococcus aureus in vitro

Article Title: Piper betle essential oil enhances antibiotic susceptibility and attenuates quorum-sensing-associated virulence in Staphylococcus aureus in vitro

Article References: Bui, L. M., Dao, M. D., Nguyen, N. T., Le, X.-T., & Do, A. D. (2026). Piper betle essential oil enhances antibiotic susceptibility and attenuates quorum-sensing-associated virulence in Staphylococcus aureus in vitro. 3 Biotech, 16(10), Article 441. https://doi.org/10.1007/s13205-026-05077-3

Image Credits: AI Generated

DOI: 10.1007/s13205-026-05077-3

Keywords: Piper betle, essential oil, Staphylococcus aureus, antibiotic resistance, quorum sensing, LuxS/AI-2, antivirulence, biofilm, antibiotic potentiation, agrA, adaptive evolution, natural products